Murepavadin
- Generic Name
- Murepavadin
- Drug Type
- Small Molecule
- Chemical Formula
- C73H112N22O16
- CAS Number
- 944252-63-5
- Unique Ingredient Identifier
- 0D02GRY87Z
Overview
Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
Background
Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/07/10 | Phase 3 | Terminated | Polyphor Ltd. | ||
2018/01/24 | Phase 3 | Terminated | Polyphor Ltd. | ||
2016/09/13 | Phase 1 | Completed | Polyphor Ltd. | ||
2014/06/05 | Phase 1 | Completed | |||
2014/04/10 | Phase 1 | Completed | Polyphor Ltd. | ||
2014/03/26 | Phase 2 | Terminated | Polyphor Ltd. | ||
2014/03/26 | Phase 2 | Completed | Polyphor Ltd. |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No China products found
No China products found for this drug
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug
© Copyright 2025. All Rights Reserved by MedPath